SMT KASHIBAI NAVALE MEDICAL COLLEGE Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2010
NCT02540642
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Smt. Kashibai Navale Medical College and General Hospital | Smt Kashibai Navle Medical College & Gen Hospital

Active Ingredients

Drugs in Phase 3 Trials (4)

ayurvedic suved (1 trial)

bovine colostrum (1 trial)

folic acid (1 trial)

saccharin (1 trial)

Drugs in Other Trials (1)

mecobalamin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cerebrovascular Disorders (Phase 3)

Coronary Artery Disease (Phase 3)

Epilepsy (Phase 3)

Heart Diseases (Phase 3)

Myocardial Ischemia (Phase 3)

Peripheral Arterial Disease (Phase 3)

Peripheral Vascular Diseases (Phase 3)

Thrombosis (Phase 3)

Vascular Diseases (Phase 3)

Venous Thrombosis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 5